Procaine HCL Injectable Recalled Due to Sterility Assurance Concerns
Tailor Made Compounding is recalling Procaine HCL 2% injectable solution due to lack of sterility assurance. The recall affects 58 vials distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: No illnesses or hospitalizations have been reported; the hazard is theoretical risk of contamination due to unconfirmed sterility. This matches the High severity criterion: 'risk-of-harm products where injury has not yet been reported.'
Plain-English summary
Tailor Made Compounding is recalling Procaine HCL 2% (20 mg/mL) injectable solution in 30 mL vials due to lack of assurance of sterility. The affected batches are: #10112102A2 (expires 4/9/2022), #11302101A1 (expires 5/29/2022), and #01242201A1 (expires 5/31/2022). A total of 58 vials have been distributed.
The recall covers product distributed nationwide in the United States and Puerto Rico. Injectable medications require strict sterility assurance. The company determined it could not provide adequate assurance that these vials met sterility requirements.
Consumers who have received or possess any of the recalled vials should not use them and should contact their healthcare provider or pharmacy for guidance. Healthcare facilities should quarantine any remaining stock of the affected batches.
The recalled product
- Product
- Procaine HCL 2% (20mg/mL), 30 ml-vial, Refrigerate, Tailor Made Compounding
- Manufacturer
- TMC Acquisition LLC dba Tailor Made Compounding
- Category
- Drug — Compounded Injectable
- Hazard
- sterility-assurance
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Batch#: 10112102A2
- Exp 4/9/2022
- 11302101A1
- Exp 5/29/2022
- 01242201A1
- Exp 5/31/2022.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27